Prevention & Chronic Conditions

Broadcast

Assessing the Shift Towards Personalised Medicine – Part 2

Sophia Ambruso, Paolo Mulatero

About

Cardiovascular disease (CVD) is a significant and ever-growing problem in the UK, accounting for nearly one-third of all deaths and leading to significant morbidity. Globally CVD accounts for 31% of mortality, mainly from heart disease and cerebrovascular accident.

The burden of CVD can be ameliorated by careful risk modification and primary prevention is an important priority for all developers of health policy. Strong consensus exists between international guidelines regarding the necessity of smoking cessation, weight optimisation and exercise, although guidelines have slightly different approaches to hypertension and vary considerably regarding their approach to optimal lipid profile, which remains a contentious issue.

Articles

Viewpoint on Arterial Hypertension

Published:

21 March 2025

Citation:

European Cardiology Review 2025;20:e06.

HsCRP in ASCVD

Published:

21 March 2025

Citation:

US Cardiology Review 2025;19:e06.

Complete Revascularisation Following Acute MI

Published:

21 March 2025

Citation:

Interventional Cardiology 2025;20:e10.

Apabetalone: Evidence and Outcomes Related to Cardiovascular Health

Published:

28 February 2025

Citation:

European Cardiology Review 2025;20:e04.